/ CompletedNot Applicable [Translation] Human bioequivalence study of ibuprofen sustained-release capsules
主要目的:比较空腹和餐后给药条件下受试制剂江西铜鼓仁和制药有限公司提供的布洛芬缓释胶囊(规格:0.3 g)与参比制剂中美天津史克制药有限公司持证的布洛芬缓释胶囊(商品名:芬必得®;规格:0.3 g)在中国健康参与者体内吸收程度和吸收速度的差异,评价两制剂的生物等效性。
次要目的:评价空腹及餐后条件下,受试制剂与参比制剂在中国健康参与者体内的安全性。
[Translation] Primary objective: To compare the absorption extent and rate of absorption of the test formulation (ibuprofen sustained-release capsules, 0.3 g, supplied by Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd.) and the reference formulation (ibuprofen sustained-release capsules, 0.3 g, certified by Sino-American Tianjin SmithKline Pharmaceutical Co., Ltd.) in healthy Chinese participants under fasting and postprandial administration conditions, and to evaluate the bioequivalence of the two formulations.
Secondary objective: To evaluate the safety of the test formulation and the reference formulation in healthy Chinese participants under fasting and postprandial administration conditions.
100 Clinical Results associated with Jiangxi Tonggu Renhe Pharmaceutical Co. Ltd.
0 Patents (Medical) associated with Jiangxi Tonggu Renhe Pharmaceutical Co. Ltd.
100 Deals associated with Jiangxi Tonggu Renhe Pharmaceutical Co. Ltd.
100 Translational Medicine associated with Jiangxi Tonggu Renhe Pharmaceutical Co. Ltd.